Joan Lunden Discusses Her TNBC Diagnosis

Video

Joan Lunden discusses the diagnostic approach that led to the early detection of triple-negative breast cancer, which was undetected by mammogram and 3D mammogram but was detected with ultrasound.

Joan Lunden discusses the diagnostic approach that led to the early detection of triple-negative breast cancer, which was undetected by mammogram and 3D mammogram but was detected with ultrasound.

Lunden recounts an interview with Susan M. Love, MD, where she discovered the need for ultrasound, as a result of her dense breast tissue. It was this revelation and procedure that greatly impacted the stage of disease at diangosis and overall prognosis, Lunden says.

Joan Lunden will be delivering the keynote address at the32nd Miami Breast Cancer Conference.

Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
Related Content